In skeletal muscle development, the myogenic regulatory factors myf5 and myoD play redundant roles in the specification and maintenance of myoblasts, whereas myf6 has a downstream role in differentiating myocytes and myofibers. It is not clear whether the redundancy between myf5 and myoD is within the same cell lineage or between distinct lineages. Using lineage tracing and conditional cell ablation in mice, we demonstrate the existence of two distinct lineages in myogenesis: a myf5 lineage and a myf5-independent lineage. Ablating the myf5 lineage is compatible with myogenesis sustained by myf5-independent, myoD-expressing myoblasts, whereas ablation of the myf6 lineage leads to an absence of all differentiated myofibers, although early myogenesis appears to be unaffected. We also demonstrate here the existence of a significant myf5 lineage within ribs that has an important role in rib development, suggested by severe rib defects upon ablating the myf5 lineage.
INTRODUCTION
Transient condensations of paraxial mesoderm, known as somites, are the major source of skeletal muscle in vertebrates. Somites differentiate into dorsolateral dermomyotome (source of skeletal muscle and dermis) and ventromedial sclerotome (source of ribs and vertebrae). Myoblasts are proliferating progenitors of the myogenic lineage that differentiate into myocytes, and several myocytes fuse to form mature multinucleated myofibers (Buckingham et al., 2003; Parker et al., 2003) . Myogenesis involves complex transcriptional networks in which the basic helix-loop-helix domain containing myogenic regulatory factors (MRFs) myf5, myoD, myf6 (mrf4), and myoG is downstream to the paired domain transcription factors pax3 and pax7 (Parker et al., 2003; Pownall et al., 2002) .
Relatively normal myogenesis in myf5 À/À and myoD À/À mice, absence of myogenesis due to loss of myoblasts in myf5 À/À myoD À/À double null mice, and lack of differentiated myofibers in myoG À/À mice collectively suggest a genetic hierarchy in which myf5 and myoD have an upstream, redundant role in specification and maintenance of myoblasts, whereas myoG has a downstream role in differentiating myocytes and myofibers (Braun and Arnold, 1995; Braun et al., 1992; Hasty et al., 1993; Nabeshima et al., 1993; Rudnicki et al., 1992 Rudnicki et al., , 1993 . However, the basis of functional redundancy between myf5 and myoD has been a matter of debate. Whereas the serial lineage model assumes expression of both genes within the same lineage, the parallel lineage model purports the existence of distinct lineages. Similar to myoG, initial knock out studies implicated myf6 in terminal differentiation (Braun and Arnold, 1995; Patapoutian et al., 1995; Zhang et al., 1995) . A subsequent study, however, showed that myf5 À/À myoD À/À double mice null lacking myoblasts were also deficient in myf6, and restoring myf6 expression in these mice partially rescued embryonic myogenesis, thereby calling to question the position of myf6 in the genetic hierarchy (Kassar-Duchossoy et al., 2004) . The lateral part of the dermomyotome is thought to play a role in the development of distal rib (Hirao and Aoyama, 2004; Kato and Aoyama, 1998) . Severe rib anomalies in myf5 À/À as well as myf6 À/À mice suggested a role for myf5 and myf6 in rib morphogenesis Yoon et al., 1997) , but their relative involvement was unclear. Rib anomalies associated with myf6 À/À were proposed to be the result of cis effects of the myf6 À/À null on the linked myf5 locus (Kaul et al., 2000; Yoon et al., 1997) . However, a conditionally generated myf5 À/À mutant, developed subsequently, showed no rib defects, and the authors concluded that the previously documented rib anomalies were due to long-range cis effects of the neo cassette on a putative distal gene (Kaul et al., 2000) . Although the above-described observations appear to rule out a direct role of the myf5 gene itself on rib formation, the significance of the myf5 cell lineage in rib development is not known.
In this study, we use conditional cell ablation and lineage tracing in mice to demonstrate that myf5 is expressed in only a subset of developing myoblasts. Early ablation of myf5-expressing cells during embryogenesis is compatible with myogenesis, sustained by a myf5-independent myoblast lineage. Surprisingly, such a redundancy does not exist for the myf5 lineage in developing ribs, and loss of this lineage leads to a severe mutant rib phenotype. We also demonstrate an expansion in the myoDexpressing myoblast population upon ablating myf5-expressing cells, suggesting remarkable adaptability of the myogenic program to developmental insults. However, ablating the genetically downstream myf6-expressing cells has the opposite effect of preserving normal rib morphogenesis, while eliminating differentiated myofibers, ascertaining that myf6 plays a predominant role in differentiated cells of skeletal muscle.
RESULTS
Alleles of myf5 and myf6 Cre Drivers: Cis Effect of Selection Cassette myf5 and myf6 are linked genes on mouse chromosome 10. myf5-cre and myf6-cre mice ( Figure 1A) were previously generated in our laboratory and harbor an IRES-CRE-FRT-NEO-MC1-FRT sequence in the 3 0 UTR of the respective genes (Haldar et al., 2007; Keller et al., 2004) . Previous reports suggested the cis effects of the selection cassette on the linked myf5 and myf6 loci as a cause of rib anomalies (Kaul et al., 2000) . Although myf5-ICN and myf6-ICN mice (''ICN'' denotes IRES-CRE-NEO-MC1) lack any rib phenotype in the homozygous or heterozygous state, we hypothesized that the exogenous MC1 promoter could have a local cis effect. myf6-ICN and myf5-ICN mice were bred to flp-e mice (Rodriguez et al., 2000) , thereby removing the MC1-Neo selection cassette (Figures 1B and 1C) and generating two alleles for each of these Cre drivers: myf5-ICN, myf5-NN, myf6-ICN, and myf6-NN (''NN'' denotes ''no neo'').
Semiquantitative real-time RT-PCR and reporter-based lineage analysis revealed that the presence of the selection cassette in the 3 0 UTR of myf6 or myf5 downregulates expression of the respective genes. This is demonstrated by significantly reduced myf6 expression and by the myf6 lineage in myf6-ICN heterozygous mice ( Figures 1D and 1H ) compared to myf6-NN heterozygous mice ( Figures 1E and 1I) . Similarly, myf5 expression and its lineage are significantly reduced in myf5-ICN heterozygous mice ( Figures 1F and 1J ) compared to myf5-NN heterozygous mice ( Figures 1G and 1K ). The expression of the linked gene (myf5 expression in myf6-NN and vice versa) was not affected in the NN alleles, and expression of myf5 and myf6 in the heterozygous NN alleles was comparable to wild-type (Figures 1E and 1G) . This underscores the importance of selection cassette removal in developmental studies and is the justification of our use of the NN allele in subsequent analysis.
The Myogenic Lineage of myf5 myf5 is involved in myoblast specification and maintenance (Parker et al., 2003; Pownall et al., 2002) . myf5-NN mice were bred to ROSA-LacZ (R-LZ) reporter mice (Soriano, 1999) . The resulting myf5-NN/R-LZ embryos revealed the expected distribution of the myf5 lineage in whole mount (Figures 2Aa-2Ac ; Figures S1Aa and S1Ab; see the Supplemental Data available with this article online) and in sections (Figure 2Ad ; Figures S1Ac and S1Ad). Cre-induced expression of b-galactosidase (b-gal) recapitulates the myf5 lineage, as suggested by consistent colocalization of the Myf5 protein with b-gal on sections (Figure 2Ae) . myf5-NN mice were then bred to reporter mice conditionally expressing the nuclear-localized b-gal reporter gene from the CAG promoter (nLacZ mouse line, P.T. and M.R.C., unpublished data) to generate myf5-NN/nLacZ mice. Myoblasts differentiate into myocytes that fuse to form multinucleated myofibers. Therefore, if all myoblasts express myf5, then all myonuclei within myf5-NN/nLacZ should express b-gal. Surprisingly, we detected b-gal in only a fraction of adult myonuclei based on both immunohistochemistry, a more specific method (Figures 2Ba-2Bc) , and enzymatic detection of b-gal activity, a more sensitive method (Figures 2Bd and 2Be ). This was true for both fast-type (Figures 2Ba and 2Bb ) and slow-type myofibers (Figure 2Bc ). Intercostals and leg flexors of myf5-NN/nLacZ, used as representative musculature, were sectioned and labeled with anti-MyHC (skeletal muscle specific), anti-b-gal (myf5 lineage marker), and DAPI (non-specific nuclear marker). The number of b-gal-positive nuclei within MyHC-positive myofibers were counted and divided by the total number of nuclei (b-gal positive and/or DAPI positive) within MyHC-expressing myofibers. Based on this strategy, $35% of myonuclei appeared to be a lineage of myf5 (2012 nuclei counted). Myonuclei are located peripherally, and there is a small probability of erroneously counting adjacent nonmyogenic connective tissue nuclei within the total pool of myonuclei used in the calculation. Another possible source of error could be the sensitivity of the technique. Considering these probable sources of error, we believe that the final contribution of myf5 to adult musculature could be as high as 50%. To rule out mosaic activity of the CAG promoter in myonuclei of nLacZ reporter mice, we bred the nLacZ mice to hprt-cre mice (Tang et al., 2002) , which express Cre recombinase at the single-cell zygotic stage. All myonuclei of hprt-cre/nLacZ mice showed b-gal, ruling out promoter mosaicism as a potential cause of the observed partial myogenic contribution of the myf5 lineage ( Figure S1B ).
The myf5 Lineage in Embryonic Myogenesis myf5-NN mice were bred to transgenic ZEG reporter mice, which express green fluorescent protein (GFP) in response to Cre (Novak et al., 2000) . Based on GFP and MyoD expression in E12.5 ZEG/myf5-NN embryos, we identified three populations of cells: cells expressing GFP only (myf5 lineage not expressing myoD), cells expressing myoD only (myoD-expressing cells not derived from myf5), and cells expressing GFP and MyoD ( Figure 2C ; Figures S2Aa and S2Ad) . This suggests the existence of myf5-independent (MyoD-positive, GFP-negative) and myf5-expressing (GFP-positive) myoblasts. Approximately 71% of the total MyoD expression in the epaxial region ( Figure 2C , left, blue boxes) and 57% in the hypaxial region ( Figure 2C , right, gray boxes) occurred within the myf5 lineage, suggesting either a predominant role or an earlier appearance of the myf5 lineage in the epaxial compared to the hypaxial region. Approximately 32% of the myf5 lineage showed MyoD expression in the epaxial region, and 39% showed expression in the hypaxial region ( Figure 2C ), suggesting the presence of either nonmyogenic myf5 lineages or MyoD-negative myoblasts. Most of the MyoD-negative myf5 lineages are located superficially in the epaxial domain ( Figure S2Aa , arrow), are negative for MyHC ( Figure S2Ab , arrow), and probably represent nonmyogenic dermal precursors (Hadchouel et al., 2000) . Differentiating myocytes expressing MyHC (Figures S2Ab and S2Ae) and MyoG (Figures S2Ac and S2Af) were found within and outside the myf5 lineage in epaxial and hypaxial regions, suggesting that both the myf5 and myf5-independent lineages contribute to embryonic musculature. Moreover, Myf5 and MyoD proteins do not always colocalize at various embryonic stages ( Figure S2B ), further supporting the notion of distinct myoblast lineages.
The myf5 Lineage Is Dispensable in Myogenesis
Our results suggested that all myonuclei are not derived from myf5-expressing cells. We then asked if the myf5 lineage is Developmental Cell myf5 Lineage Analysis required for myogenesis. myf5-NN mice were bred to ROSA-DTA (R-DTA) mice conditionally expressing the highly potent diphtheria toxin (DTA) from the ROSA locus (Wu et al., 2006) . Surprisingly, despite ablating the myf5 lineage, myogenesis was preserved, as demonstrated by the presence of myofibers of both the fast type ( Figure 2Da ) and the slow type ( Figure 2Db ). Muscles were present in all anatomical regions surveyed (Figures S3Aa-S3Ad), and myofibers had normal morphology on sections ( Figure 2Dc ). However, these pups do not survive after birth due to a fatal rib anomaly (discussed later). The functional integrity of the musculature was demonstrated by spontaneous and stimulus-induced mobility in myf5-NN/R-DTA full-term embryos delivered by C-section, whereas ultrastructural integrity was demonstrated by electron microscopy ( Figure 2Dd ). It is noteworthy that whereas the myf5-NN/R-DTA mice die perinatally with severe rib cage defects, 90% of the myf5-ICN/R-DTA mice are viable, with a normal life span, and their musculature appears to be similar to that of myf5-NN/R-DTA mice based on histology (Figures S3Ba and S3Bb) .
Subtle downregulation of myf5 in myf5-NN mice (similar to the ICN allele), which is undetectable in the heterozygous state (analyzed in Figures 1G and 1K ), may allow a small fraction of myoblasts to survive and proliferate to form musculature. This, however, seems unlikely since Myf5 expression in myf5-NN is unperturbed in even the homozygous state ( Figure S3C ).
Inefficient killing by DTA could account for ongoing myogenesis in myf5-NN/R-DTA mice. To rule this out, we generated ZEG/ myf5-NN/R-DTA embryos and observed the absence of the fluorescent myf5 lineage within these embryos (Figures 2Ee and 2Ef ) compared to ZEG/myf5-NN (Figures 2Ea and 2Eb ) embryos at E12.5. In sections, occasional cells expressing GFP (the myf5 lineage) are observed very rarely within ZEG/myf5-NN/R-DTA embryos (Figures 2Eg and 2Eh) , a frequency that is almost negligible when compared to littermate ZEG/myf5-NN embryos ( Figures  2Ec and 2Ed) ; this finding reflects the interval between Myf5 expression and DTA-mediated cell death, which is $12-24 hr (Wu et al., 2006) . Further investigation into DTA-mediated myf5 lineage ablation revealed that, although the myf5 lineage is absent ( Figures 2Ee and 2Ef ), myf5 transcripts ( Figure S4A ) and proteins (Figures S4B and S4C) that are detectable at E11.5 are greatly reduced and are dramatically reduced further with increasing embryonic age such that by E13.5 Myf5 proteins are essentially undetectable by western blot ( Figure S4B ) and are barely detectable based on immunohistochemistry ( Figure S4C ). Furthermore, a significant population of Myf5-expressing cells at E11.5 in myf5-NN/R-DTA mice is already undergoing apoptosis ( Figure S4Ce ). These results demonstrate that in vivo cell killing via DTA is associated with a time-lag between the onset of ''DTA-inducing'' gene expression (in this case, myf5) and DTAinduced apoptosis that has to be accounted for when analyzing lineage ablation by using this system. Ongoing myogenesis within ZEG/myf5-NN//R-DTA embryos based on MyoD and MyoG expression (Figures 2Eg and 2Eh) suggests that embryonic myogenesis is not significantly perturbed in the absence of the myf5 lineage. Real-time RT-PCR analysis of myf5-NN/R-DTA embryos between E10.5 and Developmental Cell myf5 Lineage Analysis E13.5 revealed significantly higher levels of myoD transcripts ( Figure 2F ) compared to wild-type by E13.5, suggesting an expansion of myf5-independent, myoD-expressing myoblasts to compensate for the loss of the myf5 lineage. Unlike myoD, there is no significant difference in myf6 expression within myf5-NN/R-DTA embryos at these stages ( Figure S3D ), suggesting that loss of the myf5 lineage does not affect the pool of differentiating myocytes, indicating efficient compensation by myf5-independent lineages.
The myf6 Lineage Is Indispensable in Myogenesis myf6 is believed to be genetically downstream of myf5 and to act in differentiated cells of the skeletal muscle lineage. The myf6 lineage is detectable by E10.5 (Figures 3Aa and 3Ab) and comprises a majority of, but not all, adult myonuclei, based on enzymatic ( Figure 3Ac ) and antibody-based (Figure 3Ad ) detection of b-gal within myf6-NN/nLacZ mice. Significant Myf6 expression also occurs in adult musculature (Figure 3Ae ). myf6-NN mice were bred to ROSA-YFP (R-YFP) reporter mice (Srinivas et al., 2001) , and the myf6 lineage was found to comprise only a small fraction of cells expressing myoD, myoG, and myHC ( Figures  3Ba-3Bc ) within E14.5 myf6-NN/R-YFP embryos, suggesting that myf6 makes a minor contribution in early myogenesis. However, we observed a complete lack of differentiated myofibers in the newborn myf6-NN/R-DTA pups that were immobile and died soon after birth. On sections, basophilic clumps of cellular debris were observed in locations of skeletal musculature (Figures 3Ca  and 3Cb ), suggesting that skeletal muscles were formed prior to DTA-mediated killing. Robust expression of Myf5, MyoD, and MyoG within E12.5 myf6-NN/R-DTA embryos suggested that the absence of the myf6 lineage does not significantly compromise early embryonic myogenesis (Figures 3Da-3Dc) .
The number of apoptotic cells within myf6-NN/R-DTA embryos increased with embryonic age, as more and more differentiated cells of myogenic lineage express Myf6 and consequently DTA (Figures 3Ea and 3Eb) , such that by E18.5 all differentiated myofibers were either already dead (extracellular patchy staining with MyHC) or dying (positive for activated caspase-3). These observations support the existing concept that myf6 plays a primary role in differentiated cells of the myogenic lineage and is not crucial in early myogenesis.
The myf5 Lineage in Rib Morphogenesis
Previous studies with targeted alleles of myf5 replaced with the b-gal reporter gene showed the presence of b-gal-expressing rib chondrocytes in null, but not in heterozygous, mice, leading the authors to suggest that the absence of myf5 leads to misincorporation of the myf5 lineage in ribs . We observed significant myf5 lineage within ribs of both myf5-NN/R-LZ (Figures 4Aa, 4Ab , 4Ae, and 4Af) and myf5-ICN/R-LZ mice (Figures 4Ag and 4Ah) , which comprised mostly chondrocytes and some cells in perichondrium (Figure 4Ab ). The costochondral (Figures 4Af and 4Ah , arrows) and costosternal ( Figures  4Ae and 4Ag, arrows) regions of ribs were particularly rich in the myf5 lineage and appeared smaller in myf5-ICN/R-LZ (Figure 4Ah , arrow) compared to myf5-NN/R-LZ mice (Figure 4Af, arrow) at the costochondral region. This apparent quantitative difference in the rib lineage of myf5 within the two alleles of myf5-cre mice (myf5-NN and myf5-ICN) translates into striking differences in the rib phenotype when these mice are bred to R-DTA mice. Whereas myf5-NN/R-DTA newborn pups have severely deformed ribs (Figures 4Ba-4Bc ) and die immediately after birth, apparently due to their inability to breathe, myf5-ICN/R-DTA mice show normal rib cages, with few mild anomalies such as occasional waviness of floating ribs (Figures  4Ca-4Cc) . The cartilaginous portion of the ribs shows fusions (Figure 4Ba, arrow) and loss of symmetric bilateral attachment to the sternum (Figure 4Bb, arrow) , and the osseous portion shows occasional ''knob-like'' protrusions (Figure 4Bc, arrows) in the myf5-NN/R-DTA mice. These anomalies are detectable even at early embryonic stages, whereas heterozygous myf5-NN or R-DTA control mice show normal rib cages ( Figures  S5a-S5d) .
The rib defects seen upon myf5 lineage ablation could be due to extensive structural damage to developing somites. If this were true, then ablation of other somitic myotomal lineages, such as that of pax3 or pax7, should recapitulate the rib phenotype of myf5-NN/R-DTA. Whereas pax3-cre/R-DTA mice suffer extensive disruption of development not compatible with embryogenesis (data not shown), pax7-cre/R-DTA newborn pups show no rib cage anomalies (Figures 4Da-4Dc) , and pax7 lineages were absent from ribs ( Figure 4Dd ). This indicates that nonspecific somitic damage is probably not the cause of rib anomalies upon myf5 lineage ablation. Intercostal musculature of myf5-NN/R-DTA mice appears to be normal based on histology and electron microscopy. Moreover, ablation of the myf6 lineage, which is absent in ribs (Figure 4Ed ), eliminates all intercostal musculature while preserving rib development (Figures 4Ea-4Ec ). These findings seem to rule out abnormal intercostal musculature as a cause of rib mispatterning in the absence of the myf5 lineage. Therefore, the myf5 lineage appears to play a direct role in rib development. Furthermore, electron microscopy of the mispatterned ribs of myf5-NN/R-DTA shows no obvious ultrastructural anomalies, suggesting the absence of any primary chondrocyte defect (Figures S5e and S5f) .
DISCUSSION
Targeted loss-of-function analyses in mice demonstrated functional redundancy between myf5 and myoD in the specification and maintenance of myoblasts. However, it was not clear whether the redundancy is within the same cell lineage (serial lineage model) or between distinct lineages (parallel lineage model). One study attempted to address this in vitro by showing that ablation of either myf5-or myoD-expressing embryonic stem cells did not compromise their myogenic line of differentiation in culture (Braun and Arnold, 1996) , whereas another study suggested distinct roles of myf5 and myoD in epaxial and hypaxial musculature, respectively (Kablar et al., 1997) , raising the possibility of multiple myogenic lineages. Here, we demonstrate the existence of two distinct myogenic lineages: a myf5 lineage and a myf5-independent lineage (MyoD expressing), which seem to be the basis of functional redundancy between myf5 and myoD. The presence of such intercellular redundancy in terms of lineage commitment during embryogenesis reflects the evolution of the myogenic pathway and provides for an inbuilt safeguard against potential disruption of the myogenic program.
Developmental Cell myf5 Lineage Analysis
Myf5 and MyoD expression are not mutually exclusive, as suggested by widespread expression of MyoD within the myf5 lineage, nor are they coexpressed, as suggested by mostly distinct expression of Myf5 and MyoD. This suggests that, under normal circumstances, most of the myogenic lineage of myf5 eventually expresses MyoD, or vice versa. The presence of skeletal musculature in the absence the myf5 lineage, however, suggests that such sequential expression is not required for myogenesis. Compared to the final contribution of the myf5 lineage to adult myonuclei (about 50%), a higher fraction of myoblasts (71% in epaxial musculature and 57% in hypaxial musculature) comprises a lineage of myf5 at E12.5, suggesting that MyoD may not be expressed in all myoblasts. Therefore, myoD-independent myoblasts may exist in a manner similar to myf5-independent myoblasts that we describe here. However, we may have missed a significant proportion of the MyoD expression outside the myf5 lineage based on the reported variability of Myf5 and MyoD expression with the cell cycle (Kitzmann et al., 1998) . Another possibility could be that more myf5-independent lineages contribute to myogenesis at later embryonic stages (after E12.5), thereby reducing the fraction of the final myf5 lineage in the adult musculature. In either scenario, it is not certain at this time whether the myf5-independent compartment is a single compartment or is heterogeneous based on MRF expression.
Cells expressing myf5 undergoe DTA-mediated apoptosis within myf5-NN/R-DTA embryos, precluding any cell-autonomous differences in the levels of myoD secondary to the absence of myf5. Therefore, an increased number of myoD transcripts in myf5-NN/R-DTA embryos reflects an increased number of myoD-expressing cells that probably compensate for the loss of the myf5 lineage to restore normal myogenesis. It would be interesting to know how the myogenic program maintains a balance between these distinct lineages and Skeletal muscle of myf5-NN/R-DTA appear to be indistinguishable from that of myf5-ICN/R-DTA based on histology. Therefore, myf5-NN/R-DTA mice, like myf5-ICN/R-DTA mice, would most likely have had a normal lifespan if not for the severe rib defects. It is remarkable that the lineage of myf5, an MRF, is dispensable in myogenesis but is required for rib development. Because a conditionally generated myf5 null mouse that lacks rib defects has been described, it is the myf5 cell lineage, not the myf5 gene, that is critical for rib development, which suggests that myf5 expression is not exclusive to the myogenic lineage. In this regard, it is noteworthy that lateral aspects of cervical vertebrae also show the presence of the myf5 lineage ( Figure S5g ). Transient expression of myf5 in presomitic mesoderm has been reported (Cossu et al., 1996) , and it is possible that the presomitic cells transiently expressing myf5 are the primary source of the substantial nonmyogenic lineages of myf5, whereas somitic cells initiating myf5 expression are the primary source of myf5's myogenic lineage. Whether somitic expression of myf5 occurs within the lineages of presomitic cells that had transiently expressed myf5 as well as the identity of the subset of myf5-expressing cells that are involved in rib development are currently under investigation. In summary, we demonstrate here the existence of two independent lineages in myogenesis and show a role of the myf5 lineage in rib development by using lineage analysis in conjunction with lineage ablation, a strategy that could be effectively applied to analyze other developmental pathways.
EXPERIMENTAL PROCEDURES Animal Handling and Genotyping
All studies involving animal subjects were approved by the University of Utah Institutional Animal Care and Use Committee and were conducted strictly in accordance with the relevant protocol. myf5-cre and myf6-cre mouse lines have been described elsewhere (Haldar et al., 2007; Keller et al., 2004) . The nLacZ reporter line was generated by targeting the conditional, codon-optimized, and nuclear localization signal-containing b-gal gene to the polr2a locus, $1 kb downstream of the polyA signal. The promoter driving nLacZ expression is the CAG promoter, a hybrid promoter comprised of cytomegalovirus immediate early enhancer and the chicken b-actin promoter (Tang et al., 2002) . The specific details of this mouse line are available upon request and will be published elsewhere.
Real-Time RT-PCR
Semiquantitative real-time RT-PCR was performed by using total RNA from wild-type and mutant embryos extracted with TRIzol (invitrogen), purified, and treated with DNase. Real-time RT-PCR was performed on RNA samples (25 ng) by using the QuantiTect SYBR green RT-PCR kit (QIAGEN, Inc., Valencia, CA) and a DNA Engine Opticon 2 system (MJ Research, Waltham, MA). Results were normalized to Gapdh signals for each sample. Standards for Gapdh and all other primer sets showed similar slopes, indicating equivalent amplification kinetics. Please refer to the Supplemental Data for primer sequences.
b-Galactosidase Staining
For whole-mount staining, samples were fixed in 1% PFA, 0.2% glutaraldehyde, 0.002 M MgCl 2 , 0.025 M EGTA, and 0.02% NP-40 in 13 PBS for 2 hr at 4 C, followed by overnight staining at room temperature in 0.005 M K 3 Fe(CN) 6 , 0.005 M K 4 Fe(CN) 6 , 0.002 M MgCl2, 0.01% Na-doc, 0.02% NP-40, and X-gal substrate in 13 PBS. Ribs were cleared in 1% KOH/20% glycerol until soft tissues disappeared. Fixed and cryopreserved samples were also sectioned at 8-12 mm thickness and stained at room temperature overnight in b-gal staining solution (described above). Counterstaining was carried out with hematoxylin by following the established protocol.
Whole-Mount Skeletal Staining
Skeletal staining was carried out with Alizarin red and alcian blue by following the established protocol (Wellik and Capecchi, 2003) .
Histology and Immunodetection
Hematoxylin and Eosin staining was carried out on 4-8 mm sections of tissue fixed in 4% PFA and embedded in paraffin by following standard protocols. Fluorescence-based immunohistochemistry was performed on 8-12 mm fixed and frozen sections. Cell counting was carried out with help from ImageJ software by using the ITCN plug in (Byun et al., 2006) .
For western blot, embryonic samples from different stages of mouse development were homogenized in 200-500 ml lysis buffer (1% Triton X-100, 0.2% SDS, .001 M EDTA in 0.05 M Tri-HCl [pH 7.4]). Each sample (15 mg protein) was separated on a 8% SDS-PAGE gel, transferred onto a PVDF gel, and probed with primary antibodies, followed by horseradish peroxidase-conjugated secondary antibody. The signal was visualized by using the chemiluminescence ECL-Plus system.
Please refer to the Supplemental Data for information on antibodies used.
Electron Microscopy
Tissue samples were fixed by using 2% formaldehyde and 2% glutaraldehyde in 0.1 M PBS (pH 7.4) containing 1% osmium tetroxide, dehydrated through an ascending series of graded ethanols, and processed for embedment in Epon 812 resin. Ultrathin sections (0.75-0.5 mm) were mounted on copper grids and stained with uranyl acetate and lead citrate before observation under an electron microscope (Philips, TECNAI-T12).
Apoptosis Detection
Apoptosis was detected by using a rabbit polyclonal antibody directed against the activated, cleaved form of caspase-3 (Cell signaling). A TUNEL assay was performed by using a fluorescein In Situ Cell Death Detection Kit (Roche), and the assay was performed according to the manufacturer's instructions.
SUPPLEMENTAL DATA
Supplemental Data include information on primer sequences and antibodies used and are available at http://www.developmentalcell.com/cgi/content/ full/14/3/437/DC1/.
